Skip to main content
AmigoFish

The FDA's psychedelic sea-change: what accelerated clinical trials for psilocybin, methylone, and ibogaine mean for mental health and neuroscience research | Boris Heifets

From From Our Neurons to Yours · · 45 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Last month we saw a big shift in the federal government’s approach to psychedelic medicine.

Specifically, following an executive order by President Trump, the FDA announced (https://apnews.com/article/psychedelics-trump-fda-kennedy-drugs-mdma-afd00baa39f4300e4631d1f3eed27b7f) it is fast-tracking its review of several clinical trials of psychedelic drugs for patients with mental health disorders. The executive order also directed more funds towards psychedelic research and a review of psychedelics’ status as highly restricted Schedule 1 substances.

To help us understand what all this means for the future of psychedelic medicine and the neuroscience of psychedelics, we’re joined by Boris Heifets (https://neuroscience.stanford.edu/people/boris-heifets), an anesthesiologist at Stanford Medicine who runs a lab studying how psychedelics affect the nervous system and their impact on patients with psychiatric conditions.

Learn More

- The Heifets Lab at Stanford Medicine (https://heifetslab.stanford.edu/)

- FDA plans ultra-fast review of three psychedelic drugs following Trump directive (https://apnews.com/article/psychedelics-trump-fda-kennedy-drugs-mdma-afd00baa39f4300e4631d1f3eed27b7f) (Associated Press, 2026)

- Trump’s order on psychedelics could have far-reaching science consequences (https://www.scientificamerican.com/article/trumps-order-on-psychedelics-could-have-far-reaching-science-consequences) (Scientific American, 2026)

- Psychedelics, placebo, and anesthetic dreams (https://neuroscience.stanford.edu/news/psychedelics-placebo-and-anesthetic-dreams) (From Our Neurons to Yours, 2024)

- Pychedelics inside out — how do LSD and psilocybin alter perception? (https://neuroscience.stanford.edu/news/psychedelics-inside-out-how-do-lsd-and-psilocybin-alter-perception-part-2)(From Our Neurons to Yours, 2024)

- The power of psychedelics meets the power of placebo (https://neuroscience.stanford.edu/news/power-psychedelics-meets-power-placebo) (From Our Neurons to Yours, 2024)

- Magnesium–ibogaine therapy in veterans with traumatic brain injuries (https://www.nature.com/articles/s41591-023-02705-w#citeas) (Nature, 2024)

- Magnesium–ibogaine therapy effects on cortical oscillations and neural complexity in veterans with traumatic brain injury (https://www.nature.com/articles/s44220-025-00463-x) (Nature Mental Health, 2025)

Send us a text! (https://www.buzzsprout.com/2112871/fan_mail/new)

Thanks for listening! If you're enjoying our show, please take a moment to give us a review on your podcast app of choice and share this episode with your friends (https://www.buzzsprout.com/2112871/share). That's how we grow as a show and bring the stories of the frontiers of neuroscience to a wider audience.

We want to hear from your neurons! Email us at at neuronspodcast@stanford.edu

Learn more about the Wu Tsai Neurosciences Institute at Stanford (http://neuroscience.stanford.edu) and follow us on Twitter (https://twitter.com/stanfordbrain), Facebook (https://www.facebook.com/WuTsaiNeurosciencesInstitute), and LinkedIn (https://www.linkedin.com/company/wu-tsai-neurosciences-institute).

Back to From Our Neurons to Yours · Report a problem